Sector: MedicalAngiotech Pharmaceuticals, Inc. (NASDAQ: ANPI)
Ranking History
Scan Date: | 2/2/2010 |
Sector: | Medical |
Funamental : | 35 |
Technical : | 307 |
Performance : | 280 |
Overall: | 253 |
Number of Stocks: | 309 |
Scan Date: | 1/26/2010 |
Sector: | Medical |
Funamental : | 37 |
Technical : | 306 |
Performance : | 252 |
Overall: | 236 |
Number of Stocks: | 309 |
Scan Date: | 1/19/2010 |
Sector: | Medical |
Funamental : | 38 |
Technical : | 197 |
Performance : | 277 |
Overall: | 188 |
Number of Stocks: | 308 |
Headlines
- Angiotech Pharmaceuticals Announces Conference Call and Webcast
Feb 04, 2010 09:02 AM | ANPI
- Bullish Monday for TSX
Nov 09, 2009 10:09 AM | ANPI, CMCSA, ESI, GE, GIB
- Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009
Nov 09, 2009 07:09 AM | ANPI, BSX
- Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting
Oct 23, 2009 09:04 AM | ANPI
- BioMed News Bytes: Angiotech, BioSante, HGSI
Oct 20, 2009 11:55 AM | AIS, ANPI, GSK, HGSI, SLE
- Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission
Oct 19, 2009 04:31 PM | ANPI
- Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
Oct 09, 2009 12:36 PM | ANPI
- Angiotech Pharmaceuticals announces TAXUS(R) Liberté(R) Stent continues to demonstrate significant improvements over TAXUS(R) Express(R) Stent in small vessels and long lesions
Sep 22, 2009 02:21 PM | ANPI, BSX
- Angiotech Pharmaceuticals announces TAXUS(R) Liberte(R) Stent continues to demonstrate significant improvements over TAXUS(R) Express(R) Stent in small vessels and long lesions
Sep 22, 2009 02:20 PM | ANPI, BSX
- Haemacure fait rapport sur ses activités et annonce les résultats du troisième trimestre de 2009
Sep 14, 2009 12:33 PM | ANPI, HAE
- Angiotech's corporate partner, Boston Scientific, reports two-year SYNTAX data showing comparable safety outcomes for complex patients treated with Taxus(R) Express(R) stents and bypass surgery
Sep 02, 2009 03:30 PM | ANPI
- Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
Aug 20, 2009 08:31 AM | ANPI
- Angiotech's Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
Aug 11, 2009 08:00 AM | ANPI
- Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
Aug 06, 2009 08:31 AM | ANPI
- Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
Aug 04, 2009 08:30 AM | ANPI
- Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
Jul 16, 2009 12:51 PM | ANPI
- Angiotech Pharmaceuticals, Inc. announces conference call and webcast
Jul 06, 2009 08:30 AM | ANPI
- Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Jun 08, 2009 08:30 AM | ANPI
- Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
May 27, 2009 11:55 AM | ANPI
- SYNTAX analysis finds treatment with TAXUS(R) Express(2)(R) Stent System more cost effective than bypass surgery in patients with complex coronary artery disease system
May 20, 2009 02:11 PM | ANPI
- Form 4 ANGIOTECH PHARMACEUTICAL For: Dec 10 Filed by: Willms Arthur H (10K)
Dec 14, 2009 05:56 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Dec 10 Filed by: HOWARD DAVID T (10K)
Dec 14, 2009 05:49 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Dec 10 Filed by: MCKINNELL HENRY A (10K)
Dec 14, 2009 05:33 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Dec 10 Filed by: Brege Laura (10K)
Dec 14, 2009 05:26 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Dec 10 Filed by: Brown Edward M (10K)
Dec 14, 2009 05:16 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Nov 20 Filed by: Hunter William L (10K)
Nov 23, 2009 05:47 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Nov 11 Filed by: Cunliffe Sean (10K)
Nov 12, 2009 05:46 PM
- Form 4 ANGIOTECH PHARMACEUTICAL For: Sep 29 Filed by: Hunter William L (10K)
Sep 30, 2009 04:35 PM
- Form 3 ANGIOTECH PHARMACEUTICAL For: Sep 08 Filed by: Cunliffe Sean (10K)
Sep 14, 2009 06:21 PM
- Form 4/A ANGIOTECH PHARMACEUTICAL For: Aug 27 Filed by: Gross Jeffrey M (10K)
Aug 31, 2009 09:42 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ANPI
|
Compare to S&P
|
| YTD |
-15.32 %
|
-11.44 %
|
| 4 Weeks |
-21.64 %
|
-15.85 %
|
| 12 Weeks |
-19.85 %
|
-17.80 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: -2.06 %
|
|
Sales Growth in Last Quarter: -7.48 %
|
|
